DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today announced that effective March 27, 2024, the...